These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cells. Joshi P; Kooshki M; Aldrich W; Varghai D; Zborowski M; Singh AD; Triozzi PL Clin Exp Metastasis; 2016 Dec; 33(8):829-838. PubMed ID: 27565163 [TBL] [Abstract][Full Text] [Related]
3. Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma. Triozzi PL; Achberger S; Aldrich W; Crabb JW; Saunthararajah Y; Singh AD Clin Epigenetics; 2016; 8():80. PubMed ID: 27453764 [TBL] [Abstract][Full Text] [Related]
4. The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon. Triozzi PL; Achberger S; Aldrich W; Singh AD; Grane R; Borden EC J Transl Med; 2012 Dec; 10():241. PubMed ID: 23217102 [TBL] [Abstract][Full Text] [Related]
5. Activated CD11b+ CD15+ granulocytes increase in the blood of patients with uveal melanoma. McKenna KC; Beatty KM; Bilonick RA; Schoenfield L; Lathrop KL; Singh AD Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4295-303. PubMed ID: 19369244 [TBL] [Abstract][Full Text] [Related]
6. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile. Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876 [TBL] [Abstract][Full Text] [Related]
7. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients. Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348 [TBL] [Abstract][Full Text] [Related]
8. Natural Killer Group 2A Expressed on Both Peripheral CD3 Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717 [TBL] [Abstract][Full Text] [Related]
9. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Ma D; Luyten GP; Luider TM; Niederkorn JY Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912 [TBL] [Abstract][Full Text] [Related]
10. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study. Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010 [TBL] [Abstract][Full Text] [Related]
11. miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications. Ragusa M; Barbagallo C; Statello L; Caltabiano R; Russo A; Puzzo L; Avitabile T; Longo A; Toro MD; Barbagallo D; Valadi H; Di Pietro C; Purrello M; Reibaldi M Cancer Biol Ther; 2015; 16(9):1387-96. PubMed ID: 25951497 [TBL] [Abstract][Full Text] [Related]
12. Contribution of Leishmania braziliensis antigen-specific CD4+ T, CD8+ T, NK and CD3+CD56+NKT cells in the immunopathogenesis of cutaneous leishmaniasis patients: Cytotoxic, activation and exhaustion profiles. Cunha CF; Ferraz-Nogueira R; Costa VFA; Pimentel MIF; Chometon TQ; Lyra MR; Schubach AO; Da-Cruz AM; Bertho AL PLoS One; 2020; 15(3):e0229400. PubMed ID: 32203546 [TBL] [Abstract][Full Text] [Related]
13. The immune cell landscape of metastatic uveal melanoma correlates with overall survival. Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438 [TBL] [Abstract][Full Text] [Related]
14. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients. Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma. Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119 [TBL] [Abstract][Full Text] [Related]
16. The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma. Krijgsman D; De Vries NL; Andersen MN; Skovbo A; Tollenaar RAEM; Bastiaannet E; Kuppen PJK; Hokland M Cancer Immunol Immunother; 2020 Oct; 69(10):2009-2020. PubMed ID: 32399587 [TBL] [Abstract][Full Text] [Related]
17. Apoptotic cell death in conjunction with CD80 costimulation confers uveal melanoma cells with the ability to induce immune responses. Carlring J; Shaif-Muthana M; Sisley K; Rennie IG; Murray AK Immunology; 2003 May; 109(1):41-8. PubMed ID: 12709016 [TBL] [Abstract][Full Text] [Related]
18. Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma. Ulmer A; Beutel J; Süsskind D; Hilgers RD; Ziemssen F; Lüke M; Röcken M; Rohrbach M; Fierlbeck G; Bartz-Schmidt KU; Grisanti S Clin Cancer Res; 2008 Jul; 14(14):4469-74. PubMed ID: 18628461 [TBL] [Abstract][Full Text] [Related]
19. Elevated Exhaustion Levels of NK and CD8 Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D Front Immunol; 2020; 11():580237. PubMed ID: 33154753 [TBL] [Abstract][Full Text] [Related]
20. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases. Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]